Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Haemonetics (HAE) Other Operating Expenses (2017 - 2025)

Haemonetics has reported Other Operating Expenses over the past 13 years, most recently at $11.6 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 4.75% year-over-year to $11.6 million; the TTM value through Dec 2025 reached $31.1 million, down 46.6%, while the annual FY2024 figure was $2.0 million, 423.56% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $11.6 million at Haemonetics, down from $19.8 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $19.8 million in Q3 2025 and troughed at -$11.7 million in Q1 2025.
  • A 5-year average of $8.6 million and a median of $10.5 million in 2021 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: soared 1790.58% in 2023 and later crashed 162.23% in 2025.
  • Year by year, Other Operating Expenses stood at $9.6 million in 2021, then crashed by 96.02% to $382000.0 in 2022, then skyrocketed by 1709.16% to $6.9 million in 2023, then soared by 76.96% to $12.2 million in 2024, then dropped by 4.75% to $11.6 million in 2025.
  • Business Quant data shows Other Operating Expenses for HAE at $11.6 million in Q4 2025, $19.8 million in Q3 2025, and $11.4 million in Q2 2025.